CA 15-3 ASSAY FOR THE ADVIA CENTAUR SYSTEM

System, Test, Immunological, Antigen, Tumor

BAYER DIAGNOSTICS CORP.

The following data is part of a premarket notification filed by Bayer Diagnostics Corp. with the FDA for Ca 15-3 Assay For The Advia Centaur System.

Pre-market Notification Details

Device IDK012357
510k NumberK012357
Device Name:CA 15-3 ASSAY FOR THE ADVIA CENTAUR SYSTEM
ClassificationSystem, Test, Immunological, Antigen, Tumor
Applicant BAYER DIAGNOSTICS CORP. 511 BENEDICT AVE. Tarrytown,  NY  10591 -5097
ContactKenneth T Edds
CorrespondentKenneth T Edds
BAYER DIAGNOSTICS CORP. 511 BENEDICT AVE. Tarrytown,  NY  10591 -5097
Product CodeMOI  
CFR Regulation Number866.6010 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2001-07-25
Decision Date2002-02-28
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00630414598154 K012357 000
00630414598147 K012357 000
00630414598130 K012357 000
00630414598123 K012357 000
00630414461359 K012357 000
00630414461328 K012357 000
00630414461311 K012357 000
00630414461281 K012357 000
00630414294063 K012357 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.